PT Jayamas Medica Industri Tbk Statistics
PT Jayamas Medica Industri Tbk (OMED) Stock Statistics & Valuation Metrics
Total Valuation
PT Jayamas Medica Industri Tbk has a market cap or net worth of IDR 4.54T. The enterprise value is IDR 5.90T.
- Market Cap
- IDR 4.54T
- Enterprise Value
- IDR 5.90T
Share Statistics
PT Jayamas Medica Industri Tbk has 27,058,850,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,058,850,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Jayamas Medica Industri Tbk’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.46%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 10.46%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 1.62B
- Profits Per Employee
- 288.26M
- Employee Count
- 1,273
- Asset Turnover
- 0.65
- Inventory Turnover
- 1.71
Valuation Ratios
The current PE Ratio of PT Jayamas Medica Industri Tbk is 10.21. PT Jayamas Medica Industri Tbk’s PEG ratio is 0.47.
- PE Ratio
- 10.21
- PS Ratio
- 1.85
- PB Ratio
- 1.54
- Price to FCF
- 14.25
- Price to Operating Cash Flow
- 10.12
- PEG Ratio
- 0.47
Income Statement
In the last 12 months, PT Jayamas Medica Industri Tbk had revenue of 2.06T and earned 366.95B in profits. Earnings per share was 13.57.
- Revenue
- 2.06T
- Gross Profit
- 695.09B
- Operating Income
- 386.38B
- Pretax Income
- 454.93B
- Net Income
- 366.95B
- EBITDA
- 457.37B
- Earnings Per Share (EPS)
- 13.57
Cash Flow
In the last 12 months, operating cash flow was 448.25B and capital expenditures -129.84B, giving a free cash flow of 318.41B billion.
- Operating Cash Flow
- 448.25B
- Free Cash Flow
- 318.41B
- Free Cash Flow per Share
- 11.79
Dividends & Yields
PT Jayamas Medica Industri Tbk pays an annual dividend of ―, resulting in a dividend yield of 2.43%
- Dividend Per Share
- ―
- Dividend Yield
- 2.43%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.98%
- Earnings Yield
- 9.74%
Stock Price Statistics
- Beta
- 0.67
- 52-Week Price Change
- -15.58%
- 50-Day Moving Average
- 211.26
- 200-Day Moving Average
- 225.49
- Relative Strength Index (RSI)
- 28.68
- Average Volume (3m)
- 23.78M
Important Dates
PT Jayamas Medica Industri Tbk upcoming earnings date is Mar 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Mar 23, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Jayamas Medica Industri Tbk as a current ratio of 10.36, with Debt / Equity ratio of 7.94%
- Current Ratio
- 10.36
- Quick Ratio
- 6.96
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -2.32
- Interest Coverage Ratio
- 21.61
Taxes
In the past 12 months, PT Jayamas Medica Industri Tbk has paid 85.99B in taxes.
- Income Tax
- 85.99B
- Effective Tax Rate
- 0.19
Enterprise Valuation
PT Jayamas Medica Industri Tbk EV to EBITDA ratio is 6.09, with an EV/FCF ratio of 10.94.
- EV to Sales
- 1.42
- EV to EBITDA
- 6.09
- EV to Free Cash Flow
- 10.94
- EV to Operating Cash Flow
- 7.77
Balance Sheet
PT Jayamas Medica Industri Tbk has IDR 1.44T in cash and marketable securities with IDR 257.78B in debt, giving a net cash position of IDR 1.18T billion.
- Cash & Marketable Securities
- IDR 1.44T
- Total Debt
- IDR 257.78B
- Net Cash
- IDR 1.18T
- Net Cash Per Share
- IDR 43.60
- Tangible Book Value Per Share
- IDR 109.63
Margins
Gross margin is 35.12%, with operating margin of 19.54%, and net profit margin of 18.17%.
- Gross Margin
- 35.12%
- Operating Margin
- 19.54%
- Pretax Margin
- 23.12%
- Net Profit Margin
- 18.17%
- EBITDA Margin
- 23.36%
- EBIT Margin
- 20.60%
Analyst Forecast
The average price target for PT Jayamas Medica Industri Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 19.29%
- EPS Growth Forecast
- 30.72%
